Loading...
Loading...
India's cladribine imports from JORDAN total $129 across 1 shipments from 1 foreign suppliers. HIKMA PHARMACEUTICALS LLC leads with $129 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include INVITRO RESEARCH SOLUTIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for cladribine — a concentrated sourcing relationship with select suppliers from JORDAN.

HIKMA PHARMACEUTICALS LLC is the leading Cladribine supplier from JORDAN to India, with import value of $129 across 1 shipments. The top 5 suppliers — HIKMA PHARMACEUTICALS LLC — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | HIKMA PHARMACEUTICALS LLC | $129 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INVITRO RESEARCH SOLUTIONS PRIVATE LIMITED | $129 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cladribine suppliers from JORDAN to India include HIKMA PHARMACEUTICALS LLC. The leading supplier is HIKMA PHARMACEUTICALS LLC with import value of $129 USD across 1 shipments. India imported Cladribine worth $129 USD from JORDAN in total across 1 shipments.
India imported Cladribine worth $129 USD from JORDAN across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cladribine sourced from JORDAN include INVITRO RESEARCH SOLUTIONS PRIVATE LIMITED. The largest buyer is INVITRO RESEARCH SOLUTIONS PRIVATE LIMITED with $129 in imports across 1 shipments.
The total value of Cladribine imports from JORDAN to India is $129 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists